Predictive value of serum apolipoprotein B/LDL-cholesterol ratio in cardiometabolic risk: population-based cohort study

Clin Biochem. 2010 Dec;43(18):1381-6. doi: 10.1016/j.clinbiochem.2010.08.027. Epub 2010 Sep 9.

Abstract

Objectives: We determined the independent predictive value of serum apolipoprotein (apo) B/LDL-cholesterol ratio for the risk of diabetes, metabolic syndrome (MetS) and coronary heart disease (CHD).

Design and methods: Prediction of incident cases was assessed in 2466 adults at 7 years' follow-up.

Results: ApoB/LDL ratio was independently associated log-linearly with waist circumference, and, only in men, with HDL-cholesterol in a multivariable regression model. Positive partial correlations existed with fasting insulin, fibrinogen and apo A-I and, only in women, with CRP. Cox regression analyses revealed the two highest apoB/LDL quartiles to be significant determinants of diabetes, at 2-fold RRs, independently of waist circumference, fasting glucose and other confounders. However, apoB/LDL quartiles were not independently associated with CHD in either gender. Only the highest apoB/LDL quartile was associated (RR 1.46) with the development of MetS. Serum apoB/LDL-cholesterol ratio, determined by insulin resistance and in women additionally by pro-inflammatory state, is of independent predictive value for incident diabetes and weakly for MetS, but not for CHD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apolipoproteins B / blood*
  • Cholesterol, LDL / blood*
  • Cohort Studies
  • Coronary Disease / blood*
  • Female
  • Humans
  • Male
  • Metabolic Syndrome / blood*
  • Middle Aged
  • Proportional Hazards Models
  • Risk Factors
  • Turkey

Substances

  • Apolipoproteins B
  • Cholesterol, LDL